These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


200 related items for PubMed ID: 20840379

  • 1. Acute transverse myelitis and antiphospholipid antibodies in lupus. No evidence for anticoagulation.
    Katsiari CG, Giavri I, Mitsikostas DD, Yiannopoulou KG, Sfikakis PP.
    Eur J Neurol; 2011 Apr; 18(4):556-63. PubMed ID: 20840379
    [Abstract] [Full Text] [Related]

  • 2. Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome.
    Mok CC, Lau CS, Chan EY, Wong RW.
    J Rheumatol; 1998 Mar; 25(3):467-73. PubMed ID: 9517765
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful treatment of transverse myelitis in a child with systemic lupus erythematosus.
    Baca V, Sanchez-Vaca G, Martínez-Muñiz I, Ramírez-Lacayo M, Lavalle C.
    Neuropediatrics; 1996 Feb; 27(1):42-4. PubMed ID: 8677025
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transverse myelitis in antiphospholipid antibody negative systemic lupus erythematosus.
    Gude DC, Chennamsetty S, Bansal DP, Jha R.
    J Indian Med Assoc; 2013 Jun; 111(6):406-7. PubMed ID: 24761503
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Transverse myelitis affecting more than 4 spinal segments associated with systemic lupus erythematosus: clinical, immunological, and radiological characteristics of 22 patients.
    Espinosa G, Mendizábal A, Mínguez S, Ramo-Tello C, Capellades J, Olivé A, Cervera R.
    Semin Arthritis Rheum; 2010 Feb; 39(4):246-56. PubMed ID: 19022478
    [Abstract] [Full Text] [Related]

  • 10. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 11. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM.
    Arthritis Rheum; 2009 Jan 15; 61(1):29-36. PubMed ID: 19116963
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
    Cabiedes J, Cabral AR, Alarcón-Segovia D.
    J Rheumatol; 1995 Oct 15; 22(10):1899-906. PubMed ID: 8991989
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
    Descloux E, Durieu I, Cochat P, Vital Durand D, Ninet J, Fabien N, Cimaz R.
    Rheumatology (Oxford); 2008 Feb 15; 47(2):183-7. PubMed ID: 18160418
    [Abstract] [Full Text] [Related]

  • 16. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
    Seaman DE, Londino AV, Kwoh CK, Medsger TA, Manzi S.
    Pediatrics; 1995 Dec 15; 96(6):1040-5. PubMed ID: 7491218
    [Abstract] [Full Text] [Related]

  • 17. Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature.
    Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE.
    J Rheumatol; 1990 Jan 15; 17(1):89-92. PubMed ID: 2179553
    [Abstract] [Full Text] [Related]

  • 18. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar 15; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 19. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr 15; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 20. International survey on the management of patients with SLE. II. The results of a questionnaire regarding neuropsychiatric manifestations.
    Tincani A, Brey R, Balestrieri G, Vitali C, Doria A, Galeazzi M, Meroni PL, Migliorini P, Neri R, Tavoni A, Bombardieri S.
    Clin Exp Rheumatol; 1996 Apr 15; 14 Suppl 16():S23-9. PubMed ID: 9049450
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.